09:00-09:10 年會開幕–理事長致詞 Keynote speech 09:10-11:20 Anti-cancer Treatment for Unfit / Heavily Treated Patient in Palliative Care. 低劑量抗癌治療於癌症緩和醫學之運用 09:10-09:50 節拍式化療在癌症緩和醫療的角色The Role of Metronomic Chemotherapy in Cancer Palliative Care. 09:50-10:30 低劑量放射線治療在癌症緩和醫療之運用 The Role of Low-dose Radiotherapy in Cancer Palliative Care. 10:30-10:40 休 息 10:40-11:20 原發腫瘤病兆外科切除在無法切除轉移性大腸直腸癌的角色 The Role of Primary Tumor Resection in Unresectable mCRC. 11:20-12:00 從共享決策的角度談病人自主權利法 Viewing Patient Right to Autonomy Act from the Point of Shared Decision Making. 12:00-13:00 會 員 大 會 與 選 舉 13:00-13:50 真實世界證據：黃耆多醣注射劑與乳癌癌因性疲憊症 Real World Evidence: Astragalus polysaccharides Injection and Breast Cancer Patients with Cancer-related Fatigue. 14:00-14:40 如何減緩癌症病患化放療時的副作用？ How to Minimize the Side Effects During CCRT in Cancer Patients. 14:40-15:20 NEPA於化療引起之噁心嘔吐的臨床證據 Real-world Evidence of NEPA in Chemotherapy-induced Nausea and Vomiting Prevention. 15:20-15:40 休 息 15:40-16:20 如何在癌症疼痛使用ROO The Role of Rapid Onset Opioid in Cancer Pain. 16:20-17:00 治療鴉片類藥物誘發性便秘(OIC)的最新發展-Naldemedine New Developments on Opioid-Induced Constipation (OIC) Therapy – Naldemedine. 09:10-09:50 翻轉晚期乳癌命運！HER2陽性轉移性乳癌的治療新標準 Change HER Destiny Now! New Standard of Care for HER2+ Metastatic Breast Cancer Treatment. 09:50-10:30 優化HER2陽性乳癌最佳存活率之治療策略 Maximizing Benefit for HER2 Breast Cancer Patients. 10:30-10:40 休 息 10:40-11:20 PARP 抑製劑在生殖細胞 BRCA 突變併Her2 陰性晚期乳癌中的真實世界臨床應用 Real-world Utilization of PARP Inhibitor for Germline BRCA-mutated, Her2-Negative Advanced Breast Cancer. 11:20-12:00 鑑往知來：從HER2陽性乳癌治療看醫療永續 Past, Present and Future of HER2+ Breast Cancer Treatment.